Chemomab Therapeutics Ltd.
CMMB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534248
In the last 90 days, Chemomab Therapeutics Ltd. insiders filed 0 open-market purchases and 1 sale; 13 institutions reported holding it in 13F filings for Q2 2026, worth $615.3K in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Chemomab Therapeutics Ltd. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 14 | 13 | −1 |
| Shares | 3.31M | 2.89M | −423.7K (−12.8%) |
| Value | $10.6M | $4.56M | −$6.04M (−57.0%) |
New holders (2)
Institutions that held Chemomab Therapeutics Ltd. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Investments, LP | 30,263 | $48.1K | 0.00% |
| Two Sigma Advisers, LP | 11,800 | $18.8K | 0.00% |
Sold out (3)
Institutions that held Chemomab Therapeutics Ltd. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Envestnet Asset Management Inc | 12,861 | $41.2K |
| Activest Wealth Management | 7,600 | $24.3K |
| Credit Suisse AG | 1 | $3 |